Notice Type
Departmental
Consent to the Distribution of New Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution inNew Zealand of the new medicines set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Ethanol 96% v/v in 10 mL Solution for injection (ampoules) Biomed Laboratories Limited, Point Chevalier, Auckland Ethanol 96% Follitropin alfa 75IU, 150IU Powder for injection (ampoules) Laboratories Serono SA., Aubonne, Switzerland and Serono Pharma SpA., Bari, Italy Gonal-F Follitropin alfa 75IU, 150IU Powder for injection (vials) Laboratories Serono SA., Aubonne, Switzerland Gonal-F Lactulose 3.4 g/5 mL in 200 mL, 500 mL Oral solution Canlac Corporation, Victoriaville, Quebec, Canada Lac-Dol Bupivacaine hydrochloride monohydrate 1.32 mg/mL (equivalent to 1.25 mg/mL anhydrous Bupivacaine hydrochloride) and Fentanyl citrate 7.8 mcg/mL (equivalent to 5 mcg/mL Fentanyl) in 20 mL Solution for epidural injection (vial) Astra Pharmaceuticals Pty Limited, North Ryde, New South Wales, Australia Marcain with Fentanyl injection Bupivacaine hydrochloride monohydrate 1.32 mg/mL (equivalent to 1.25 mg/mL anhydrous Bupivacaine hydrochloride) and Pethidine hydrochloride 2.5 mg/mL in 20 mL Solution for epidural injection (vial) Astra Pharmaceuticals Pty Limited, North Ryde, New South Wales, Australia Marcain with Pethidine injection Tropisetron hydrochloride 5.64 mg (equivalent to 5 mg tropisetron) Capsule Sandoz Pharma Limited, Basle, Switzerland Navoban Tropisetron hydrochloride 5.64 mg (equivalent to 5 mg tropisetron) Injection (ampoules) Sandoz Pharma Limited, Basle, Switzerland Navoban Follitropin beta 100IU and sodium chloride 4.5 mg/mL in 1 mL as diluent Powder for injection (ampoules) Organon (Ireland) Limited, Swords, Co. Dublin, Ireland and Organon International BV, Oss, The Netherlands Puregon 100 Follitropin beta 150IU and sodium chloride 4.5 mg/mL in 1 mL as diluent Powder for injection (ampoules) Organon (Ireland) Limited, Swords, Co. Dublin, Ireland and Organon International BV, Oss, The Netherlands Puregon 150 Follitropin beta 50IU and sodium chloride 4.5 mg/mL in 1 mL as diluent Powder for injection (ampoules) Organon (Ireland) Limited, Swords, Co. Dublin, Ireland and Organon International BV, Oss, The Netherlands Puregon 50 Follitropin beta 75IU and sodium chloride 4.5 mg/mL in 1 mL as diluent Powder for injection (vials) Organon (Ireland) Limited, Swords, Co. Dublin, Ireland and Organon International BV, Oss, The Netherlands Puregon 75 Valaciclovir hydrochloride 556 mg (equivalent to 500 mg valaciclovir), 1112 mg (equivalent to 1000 mg valaciclovir) Tablets Wellcome Foundation Limited, Temple Hill, Dartford, Kent, United Kingdom Valaciclovir Valaciclovir hydrochloride 556 mg (equivalent to 500 mg valaciclovir), 1112 mg (equivalent to 1000 mg valaciclovir) Tablets Wellcome Foundation Limited, Temple Hill, Dartford, Kent, United Kingdom Valtrex Dated this 8th day of November 1995. KAREN O. POUTASI, Director-General of Health, pursuant to delegation given by the Minister of Health on 25 June 1993.
Publication Date
16 Nov 1995

Notice Number

1995-go7518

Page Number

4367